Description:
BASAL CELL NEVUS SYNDROME; BCNS
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Heritable Cancer Syndromes and other Cancers |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a negative result with a primer for Yq11, DYS227. |
|
Remarks |
See GM01725 Fibroblast; HLA type A28, Aw30,B5,Bw16; clinically affected |
NCBI GTR |
109400 BASAL CELL NEVUS SYNDROME; BCNS |
OMIM |
109400 BASAL CELL NEVUS SYNDROME; BCNS |
Omim Description |
BASAL CELL NEVUS SYNDROME; BCNS |
|
FIFTH PHACOMATOSIS |
|
GORLIN SYNDROME |
|
GORLIN-GOLTZ SYNDROMEHYDROCEPHALUS, COSTOVERTEBRAL DYSPLASIA, AND SPRENGEL ANOMALY, INCLUDED |
|
MULTIPLE BASAL CELL NEVI, ODONTOGENIC KERATOCYSTS, AND SKELETAL ANOMALIES |
|
NEVOID BASAL CELL CARCINOMA SYNDROME; NBCCS |
|